Apexigen
anti tumor effects of in melanoma single agent and anti combination efficacy is yor | Apexigen
Company
Deck Type
Sector
Industry
Deck date
March 2022
Slide
14 of 28
Similar slides by Apexigen
See diffirences between slides (animation)
Investor Presentation
September 2022
phase single agent durable responses in metastatic melanoma | Apexigen
Related slides by other companies
Genelux
Investor Presentation
December 2023
phase anti tumor activity as leading into combination a | Genelux
Genelux
Investor Presentation
February 2024
phase anti tumor activity as leading into combination soc aurelia regimen gratis | Genelux
Genelux
Investor Presentation
October 2023
phase anti tumor activity as leading into combination regimen prior prior | Genelux
Erasca
Investor Presentation
January 2024
eras blocked the feedback reactivation observed with or other plus inhibitor combinations | Erasca
Other recent decks by Apexigen
See all presentations (2 decks)
Investor Presentation
September 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io